angiopep-2 peptide 2 - Angiopep 2bbb 2 Angiopep-2 Peptide: A Promising Ligand for Targeted Drug Delivery Across the Blood-Brain Barrier

Angiopep-2/LRP1 The angiopep-2 peptide has emerged as a significant player in the field of targeted drug delivery, particularly for applications requiring penetration of the blood-brain barrier (BBB). This synthetic peptide, derived from the Kunitz domain of human aprotinin, exhibits a remarkable affinity for the low-density lipoprotein receptor-related protein 1 (LRP1), a key receptor involved in the transport of various molecules across biological membranes. The specific interaction of angiopep-2 with LRP1 makes it an invaluable tool for directing therapeutic and diagnostic agents to the central nervous system.

Understanding the Mechanism of Angiopep-2

The efficacy of angiopep-2 as a BBB shuttle lies in its ability to leverage the natural transport mechanisms of the brain. LRP1 receptors are highly expressed on endothelial cells of the BBB, facilitating the transcytosis of specific ligands. Angiopep-2 has been engineered to bind to these receptors, effectively hitching a ride across the barrierAngiopep-2 modification is a strategy to chemically or biotechnologically conjugateAngiopep-2 peptidesto drugs, nanocarriers, or contrast agents, with the aim .... This targeted approach offers a significant advantage over non-specific delivery methods, which often struggle to achieve therapeutic concentrations in the brain due to the protective nature of the BBB. The angiopep-2 sequence and its precise structure are critical for this high LRP1 binding efficiency.

Research has demonstrated that angiopep-2 can significantly enhance the transport of various payloads. For instance, studies involving angiopep-2-modified nanoparticles have shown improved brain-directed delivery of therapeutic agents.Angiopep-2-Cys This angiopep-2 modification can involve conjugating the peptide to nanocarriers, such as liposomes or polymeric nanoparticles, thereby equipping them with the ability to actively target the brainAngiopep-2-Cys (CAS 906480-09-9). The angiopep-2 peptide can also be conjugated to anticancer agents, increasing their efficacy by improving their ability to reach tumor sites within the brain. This is particularly relevant for challenging conditions like gliomas, where effective treatment is often hampered by poor drug penetration.

Applications and Further Developments of Angiopep-2

The potential applications of angiopep-2 peptide extend beyond simple drug deliveryOptimizing Angiopep-2 Density on Polymeric .... Its ability to cross the BBB and target specific cells has led to its investigation as a component in diagnostic tools.Engineered Extracellular Vesicles Modified by Angiopep-2 ... For example, angiopep-2 has been explored as an MRI biomarker to dynamically monitor conditions like amyloid deposition. Furthermore, angiopep-2 has been incorporated into boron-peptide conjugates for potential use in boron neutron capture therapy.

The development of angiopep-2 derivatives and related peptides is an ongoing area of research. This includes exploring retro-inverso isomers, such as DAngiopep, which are designed for enhanced stability and improved brain-targeted drug delivery. The development of angiopep-2-cys variants further expands the possibilities for conjugation and targeted deliveryFormula: C104H150N29O31 ; Product Description: ThepeptideTFFYGGSRGKRNNFKTEEY is part of theangiopepfamily derived from the Kunitz domain of human aprotinin.. Researchers are also investigating the optimization of angiopep-2 density on various delivery platforms, such as polymeric materials and extracellular vesicles, to maximize targeting efficiency. The angiopep-2 price can vary depending on the supplier and purity, with research-grade quantities available from specialized chemical suppliers.

The angiopep-2 peptide represents a significant advancement in overcoming the challenges associated with delivering therapeutics to the brain. Its specific interaction with LRP1 receptors provides a robust mechanism for crossing the BBB, opening new avenues for treating neurological disorders and improving diagnostic capabilities. As research continues, the versatility and potential of this peptide are likely to be further realized, leading to innovative therapeutic strategies. The angiopep-2 sequence and its derivatives, such as the angiopep-2 structure, are key to its functionality. Researchers are exploring various angiopep-2 peptide formulations and applications, including its use in 2 peptide and 2 peptides based delivery systems.Angiopep-2, an MRI Biomarker, Dynamically Monitors Amyloid ... The term angiopep itself refers to this class of targeting peptides.